DD287511A5 - Verfahren zur herstellung von 13-alkyl-11beta-phenylgonanen - Google Patents
Verfahren zur herstellung von 13-alkyl-11beta-phenylgonanen Download PDFInfo
- Publication number
- DD287511A5 DD287511A5 DD89330342A DD33034289A DD287511A5 DD 287511 A5 DD287511 A5 DD 287511A5 DD 89330342 A DD89330342 A DD 89330342A DD 33034289 A DD33034289 A DD 33034289A DD 287511 A5 DD287511 A5 DD 287511A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- hydroxy
- methyl
- hydroxypropyl
- phenyl
- gonadien
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0081—Substituted in position 17 alfa and 17 beta
- C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J33/002—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Epoxy Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Lubricants (AREA)
- Macromonomer-Based Addition Polymer (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3822770A DE3822770A1 (de) | 1988-07-01 | 1988-07-01 | 13-alkyl-11ss-phenylgonane |
Publications (1)
Publication Number | Publication Date |
---|---|
DD287511A5 true DD287511A5 (de) | 1991-02-28 |
Family
ID=6358021
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DD89330342A DD287511A5 (de) | 1988-07-01 | 1989-07-03 | Verfahren zur herstellung von 13-alkyl-11beta-phenylgonanen |
DD89341722A DD295638A5 (de) | 1988-07-01 | 1989-07-03 | Verfahren zur herstellung von ausgangsprodukten |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DD89341722A DD295638A5 (de) | 1988-07-01 | 1989-07-03 | Verfahren zur herstellung von ausgangsprodukten |
Country Status (17)
Country | Link |
---|---|
US (2) | US5273971A (fr) |
EP (1) | EP0349481B1 (fr) |
JP (1) | JP2956776B2 (fr) |
AT (1) | ATE129717T1 (fr) |
AU (1) | AU644060B2 (fr) |
CA (1) | CA1334668C (fr) |
DD (2) | DD287511A5 (fr) |
DE (2) | DE3822770A1 (fr) |
ES (1) | ES2080079T3 (fr) |
GR (1) | GR3018069T3 (fr) |
HU (1) | HU208021B (fr) |
IE (1) | IE70664B1 (fr) |
IL (1) | IL90826A (fr) |
NO (1) | NO180451C (fr) |
PT (1) | PT91031B (fr) |
WO (1) | WO1990000174A1 (fr) |
ZA (1) | ZA895058B (fr) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3822770A1 (de) * | 1988-07-01 | 1990-01-04 | Schering Ag | 13-alkyl-11ss-phenylgonane |
US5707982A (en) * | 1989-02-24 | 1998-01-13 | Roussel Uclaf | 19-nor-steroids |
US6790971B1 (en) * | 1989-02-24 | 2004-09-14 | Aventis Pharma S.A. | 19-Nor-steroids |
DE4018168A1 (de) * | 1990-06-01 | 1991-12-05 | Schering Ag | Ausgangsverbindungen fuer die herstellung von 10ss-h-steroiden und ein verfahren zur herstellung dieser ausgangsverbindungen |
DE4042004A1 (de) * | 1990-12-22 | 1992-06-25 | Schering Ag | 14(beta)-h-, 14- u. 15-en-11(beta)-aryl-4-estrene |
DK0683172T3 (da) * | 1994-05-19 | 1998-03-30 | Akzo Nobel Nv | 11,21-bisphenyl-19-norpregnanderivater |
DE4434488A1 (de) * | 1994-09-14 | 1996-03-21 | Schering Ag | Steroidester und -amide, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung |
US5929262A (en) * | 1995-03-30 | 1999-07-27 | The United States Of America As Represented By The Department Of Health And Human Services | Method for preparing 17α-acetoxy-11β-(4-N, N-dimethylaminophyl)-19-Norpregna-4,9-diene-3, 20-dione, intermediates useful in the method, and methods for the preparation of such intermediates |
EP0900234B1 (fr) * | 1996-05-01 | 2000-07-05 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | Derives de progesterone substitues 21 pouvant etre utilises comme nouveaux agents antiprogestatifs |
US6900193B1 (en) * | 1996-05-01 | 2005-05-31 | The United States Of America As Represented By The Department Of Health And Human Services | Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents |
US6020328A (en) * | 1998-03-06 | 2000-02-01 | Research Triangle Institute | 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
US6262042B1 (en) | 1998-05-29 | 2001-07-17 | Research Triangle Institute | 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
US5962444A (en) * | 1998-05-29 | 1999-10-05 | Research Triangle Institute | 17β-nitro-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
KR20030029640A (ko) * | 2000-07-28 | 2003-04-14 | 악조 노벨 엔.브이. | 16 알파-메틸 또는 에틸 치환 에스트로겐 |
CA2516319C (fr) * | 2003-02-28 | 2012-09-18 | The Government Of The United States Of America, As Represented By The Se Cretary, Department Of Health And Human Services | Procede de preparation de 17.alpha.-acetoxy-11.beta.-(4-n,n-d-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione, d'intermediairesde ceux-ci et procedes de preparation desditsintermediaires |
TW200531977A (en) | 2004-03-25 | 2005-10-01 | Akzo Nobel Nv | Progesterone receptor modulators |
US20060196449A1 (en) * | 2004-09-17 | 2006-09-07 | Mockry Eldon F | Fluid heating system and method |
WO2008039482A2 (fr) * | 2006-09-26 | 2008-04-03 | The Regents Of The University Of California | Méthodes et compositions pour la prévention et le traitement du cancer |
US9517240B2 (en) | 2006-09-26 | 2016-12-13 | The Regents Of The University Of California | Methods and compositions for cancer prevention and treatment |
SI2078032T1 (sl) | 2006-10-24 | 2017-12-29 | Repros Therapeutics Inc. | Sestave in postopki za zaviranje proliferacije endometrija |
US7784843B2 (en) * | 2008-01-08 | 2010-08-31 | Toyota Motor Engineering & Manufacturing North America, Inc. | Vehicle console with sliding panel |
US8172293B2 (en) * | 2008-01-09 | 2012-05-08 | Toyota Motor Engineering & Manufacturing North America, Inc. | Vehicle electronic device support systems |
TWI539953B (zh) | 2008-04-28 | 2016-07-01 | 瑞波若斯治療學公司 | 用於治療乳癌之組成物和方法 |
SG10201504913UA (en) | 2010-03-22 | 2015-07-30 | Repros Therapeutics Inc | Compositions and methods for non-toxic delivery of antiprogestins |
WO2014164861A1 (fr) | 2013-03-12 | 2014-10-09 | Arno Therapeutics | Formes polymorphes de l'onapristone et leurs procédés d'utilisation |
US9096641B2 (en) * | 2013-06-05 | 2015-08-04 | Evestra, Inc. | Imidazolyl progesterone antagonists |
KR20170084086A (ko) | 2014-11-17 | 2017-07-19 | 아르노 테라퓨틱스 인코포레이티드 | 오나프리스톤 연장-방출 조성물 및 방법 |
JP2018528944A (ja) | 2015-09-25 | 2018-10-04 | コンテクスト バイオファーマ インコーポレイテッド | オナプリストン中間体の製造方法 |
KR20180113988A (ko) | 2015-12-15 | 2018-10-17 | 컨텍스트 바이오파마 인코포레이티드 | 비정질 오나프리스톤 조성물 및 그 제조방법 |
US20180148471A1 (en) | 2016-11-30 | 2018-05-31 | Arno Therapeutics, Inc. | Methods for onapristone synthesis dehydration and deprotection |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3971772A (en) * | 1975-01-06 | 1976-07-27 | E. R. Squibb & Sons, Inc. | Steroidal[16α,17-b]1,4-dioxanes and Steroidal[16α,17-b]1,4-dioxins |
ZA8231B (en) * | 1981-01-09 | 1982-11-24 | Roussel Uclaf | New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained |
FR2522328B1 (fr) * | 1982-03-01 | 1986-02-14 | Roussel Uclaf | Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments |
US4780461A (en) * | 1983-06-15 | 1988-10-25 | Schering Aktiengesellschaft | 13α-alkyl-gonanes, their production, and pharmaceutical preparations containing same |
ES8502612A1 (es) * | 1983-06-15 | 1985-02-01 | Schering Ag | Procedimiento para la preparacion de 13a-alquilgonanos |
FR2576025B1 (fr) * | 1985-01-14 | 1987-01-23 | Roussel Uclaf | Nouveaux steroides substitues en position 10, leur procede et les intermediaires de preparation, leur application comme medicaments, les compositions pharmaceutiques les contenant |
NZ214998A (en) * | 1985-02-07 | 1989-06-28 | Schering Ag | 13-(methyl or ethyl)-11-beta-phenyl-gonane derivatives; preparatory processes and pharmaceutical compositions |
DE3625315A1 (de) * | 1986-07-25 | 1988-01-28 | Schering Ag | 11ss-(4-isopropenylphenyl)-estra-4,9-diene, deren herstellung und diese enthaltende pharmazeutische praeparate |
DE3822770A1 (de) * | 1988-07-01 | 1990-01-04 | Schering Ag | 13-alkyl-11ss-phenylgonane |
DE3832303A1 (de) * | 1988-09-20 | 1990-04-12 | Schering Ag | 11ss-phenyl-14ssh-steroide |
-
1988
- 1988-07-01 DE DE3822770A patent/DE3822770A1/de not_active Withdrawn
-
1989
- 1989-06-30 PT PT91031A patent/PT91031B/pt not_active IP Right Cessation
- 1989-06-30 CA CA000604596A patent/CA1334668C/fr not_active Expired - Fee Related
- 1989-06-30 IL IL9082689A patent/IL90826A/en not_active IP Right Cessation
- 1989-07-03 JP JP1507188A patent/JP2956776B2/ja not_active Expired - Fee Related
- 1989-07-03 DE DE58909476T patent/DE58909476D1/de not_active Expired - Fee Related
- 1989-07-03 EP EP89730155A patent/EP0349481B1/fr not_active Expired - Lifetime
- 1989-07-03 DD DD89330342A patent/DD287511A5/de not_active IP Right Cessation
- 1989-07-03 WO PCT/DE1989/000443 patent/WO1990000174A1/fr active Application Filing
- 1989-07-03 AU AU38568/89A patent/AU644060B2/en not_active Ceased
- 1989-07-03 ZA ZA895058A patent/ZA895058B/xx unknown
- 1989-07-03 IE IE214189A patent/IE70664B1/en not_active IP Right Cessation
- 1989-07-03 ES ES89730155T patent/ES2080079T3/es not_active Expired - Lifetime
- 1989-07-03 AT AT89730155T patent/ATE129717T1/de not_active IP Right Cessation
- 1989-07-03 HU HU894130A patent/HU208021B/hu not_active IP Right Cessation
- 1989-07-03 DD DD89341722A patent/DD295638A5/de not_active IP Right Cessation
- 1989-07-03 US US07/374,809 patent/US5273971A/en not_active Expired - Fee Related
-
1990
- 1990-12-27 NO NO905609A patent/NO180451C/no unknown
-
1993
- 1993-11-02 US US08/144,474 patent/US5446036A/en not_active Expired - Fee Related
-
1995
- 1995-11-10 GR GR950403170T patent/GR3018069T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
WO1990000174A1 (fr) | 1990-01-11 |
DD295638A5 (de) | 1991-11-07 |
NO905609D0 (no) | 1990-12-27 |
ATE129717T1 (de) | 1995-11-15 |
AU644060B2 (en) | 1993-12-02 |
US5446036A (en) | 1995-08-29 |
IL90826A0 (en) | 1990-01-18 |
DE3822770A1 (de) | 1990-01-04 |
CA1334668C (fr) | 1995-03-07 |
NO180451C (no) | 1997-04-23 |
PT91031A (pt) | 1990-02-08 |
HU208021B (en) | 1993-07-28 |
JPH03505727A (ja) | 1991-12-12 |
IE892141L (en) | 1990-01-01 |
US5273971A (en) | 1993-12-28 |
ZA895058B (en) | 1990-04-25 |
PT91031B (pt) | 1994-12-30 |
JP2956776B2 (ja) | 1999-10-04 |
NO180451B (no) | 1997-01-13 |
DE58909476D1 (de) | 1995-12-14 |
IL90826A (en) | 1994-06-24 |
NO905609L (no) | 1991-02-28 |
HUT56114A (en) | 1991-07-29 |
HU894130D0 (en) | 1991-06-28 |
EP0349481A1 (fr) | 1990-01-03 |
EP0349481B1 (fr) | 1995-11-02 |
GR3018069T3 (en) | 1996-02-29 |
IE70664B1 (en) | 1996-12-11 |
ES2080079T3 (es) | 1996-02-01 |
AU3856889A (en) | 1990-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0349481B1 (fr) | 13-Alkyl-11-bêta-phénylgonanes | |
EP0254670B1 (fr) | 11-Bêta-(4-isopropenylphényl)-estra-4,9-diène, leur préparation et compositions pharmaceutiques les contenant | |
EP0283428B1 (fr) | Stéroides 19,11-bêta-pontés, leur préparation et préparations pharmaceutiques les contenant | |
EP0192598B1 (fr) | 11-Bêta-N,N-diméthylaminophenyl-estradiènes, leur préparationet compositions pharmaceutiques les contenant | |
EP0404283B1 (fr) | 11-Bêta-aryl-4-estrène, son procédé de préparation et son application comme médicament | |
DD218624A5 (de) | Verfahren zur herstellung von 13 alpha-alkylgonanen | |
EP0360369B1 (fr) | 11 Bêta-phényle-14 bêta H-stéroides | |
EP0299913B1 (fr) | 11 Bêta-phényl-estra-4,9-15-triènes, leur préparation et compositions pharmaceutiques les contenant | |
EP0411733A2 (fr) | 11-Bêta-aryl-gona-4,9-diène-3-ones | |
EP0567469B1 (fr) | 14beta-H-, 14- ET 15-EN-11beta-ARYL-4-ESTRENES | |
EP0347370A2 (fr) | Stéroides 10bêta, 11bêta pontés | |
EP0399632A1 (fr) | 9-Alpha-hydroxy-19,11-bêta ponté stéroides, leur préparation et les compositions pharmaceutiques les renfermant | |
DE3410880A1 (de) | 17-substituierte estradiene und estratriene | |
DE3504421A1 (de) | Neue 11ss-phenyl-gonane, deren herstellung und diese enthaltende pharmazeutische praeparate | |
EP0567472B1 (fr) | D-homo-(16-ene)-11 beta-aryl-4-estrenes, leur procede de production et leur utilisation comme medicaments. | |
DE69215125T2 (de) | Kardioaktive Steroide | |
WO1991018918A1 (fr) | PROCEDE DE PRODUCTION DE 10β-H-STEROIDS | |
DE2309328A1 (de) | 3-keto-7(alpha,beta)-nied.-alkyldelta hoch 5-steroide und verfahren zu ihrer herstellung | |
WO1994006819A1 (fr) | 4,5;11,12-estradienes a activite gestagene, leur procede de preparation, medicaments contenant ces estradienes ainsi que leur utilisation pour preparer des medicaments | |
DE3413036A1 (de) | 13(alpha)-alkylgonane, deren herstellung und diese enthaltende pharmazeutische praeparate | |
DE1926043A1 (de) | Neue Steroide | |
DE2101813A1 (de) | Steroidverbindungen und Verfahren zu ihrer Herstellung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENJ | Ceased due to non-payment of renewal fee |